Cargando…
Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response
BACKGROUND: Major depressive disorder is a debilitating illness, which is most commonly treated with antidepressant drugs. As the majority of patients do not respond on their first trial, there is great interest in identifying biological factors that indicate the most appropriate treatment for each...
Autores principales: | Fiori, Laura M, Lopez, Juan Pablo, Richard-Devantoy, Stéphane, Berlim, Marcelo, Chachamovich, Eduardo, Jollant, Fabrice, Foster, Jane, Rotzinger, Susan, Kennedy, Sidney H, Turecki, Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570004/ https://www.ncbi.nlm.nih.gov/pubmed/28520926 http://dx.doi.org/10.1093/ijnp/pyx034 |
Ejemplares similares
-
Serum-based microRNA biomarkers for major depression: MiR-16, miR-135a, and miR-1202
por: Gheysarzadeh, Ali, et al.
Publicado: (2018) -
miR-1202: A Primate Specific and Brain Enriched miRNA Involved in Major Depression and Antidepressant Treatment
por: Lopez, Juan Pablo, et al.
Publicado: (2014) -
Clinical value of combined detection of miR-1202 and miR-195 in early diagnosis of cervical cancer
por: Yang, Xielan, et al.
Publicado: (2019) -
miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma
por: Takashima, Yasuo, et al.
Publicado: (2020) -
Expression Change of miR-214 and miR-135 during
Muscle Differentiation
por: Honardoost, Maryam, et al.
Publicado: (2015)